Y-Biologics, Inc. (KOSDAQ:338840)

Y-Biologics Revenue

Y-Biologics had revenue of 1.55B KRW in the quarter ending June 30, 2026, with 32.85% growth. This brings the company's revenue in the last twelve months to 3.17B, down -46.81% year-over-year. In the year 2025, Y-Biologics had annual revenue of 2.91B, down -49.45%. That makes Y-Biologics the 42,007th largest company in the world by revenue and 2,557th in South Korea.

• Revenue (ttm): 3.17B
• Revenue Growth: -46.81%
• P/S Ratio: 36.98
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 117.25B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.91B	-2.85B	-49.45%
Dec 31, 2024	5.76B	2.28B	65.64%
Dec 31, 2023	3.48B	-671.48M	-16.18%
Dec 31, 2022	4.15B	-696.78M	-14.37%
Dec 31, 2021	4.85B	-1.88B	-27.99%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 8, 2026

Data Sources Report a data error